Denali Therapeutics Inc (DNLI)
Equity Ratio
72.13%
Quarterly · Period ending:
DNLI Equity Ratio
Latest reported72.13%period ending
Latest reported72.13%period ending
DNLI Quarterly Equity Ratio (93.90% → 72.13%)
Latest values, visible window
High-resolution chart · PNG
DNLI equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 72.1253% | |
| 73.1502% | |
| 88.5494% | |
| 87.7395% | |
| 88.0652% | |
| 88.3071% | |
| 89.4849% | |
| 90.6797% | |
| 92.3122% | |
| 92.0551% | |
| 89.3439% | |
| 90.423% | |
| 90.8933% | |
| 68.5926% | |
| 71.3875% | |
| 66.0882% | |
| 68.4313% | |
| 69.4948% | |
| 68.5313% | |
| 69.8138% | |
| 71.0488% | |
| 71.4118% | |
| 71.7163% | |
| 82.4577% | |
| 77.5743% | |
| 78.3645% | |
| 71.3789% | |
| 72.6721% | |
| 74.5248% | |
| 76.3599% | |
| 82.607% | |
| 84.7016% | |
| 85.7036% | |
| 87.7963% | |
| 95.7008% | |
| 91.8349% | |
| 92.1968% | |
| 93.8952% |